Ameriprise’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.53M | Sell |
82,010
-5,183
| -6% | -$98.9K | ﹤0.01% | 3088 |
|
|
2025
Q4 | $2.01M | Sell |
87,193
-6,955
| -7% | -$179K | ﹤0.01% | 2996 |
|
|
2025
Q3 | $2.53M | Sell |
94,148
-5,224
| -5% | -$125K | ﹤0.01% | 2889 |
|
|
2025
Q2 | $1.67M | Sell |
99,372
-12,091
| -11% | -$213K | ﹤0.01% | 3035 |
|
|
2025
Q1 | $1.97M | Sell |
111,463
-72,677
| -39% | -$1.46M | ﹤0.01% | 2912 |
|
|
2024
Q4 | $4.47M | Buy |
184,140
+57,129
| +45% | +$1.63M | ﹤0.01% | 2434 |
|
|
2024
Q3 | $4.72M | Sell |
127,011
-16,396
| -11% | -$611K | ﹤0.01% | 2413 |
|
|
2024
Q2 | $6.83M | Sell |
143,407
-4,283
| -3% | -$188K | ﹤0.01% | 2056 |
|
|
2024
Q1 | $5.65M | Buy |
147,690
+2,773
| +2% | +$90.2K | ﹤0.01% | 2275 |
|
|
2023
Q4 | $4.52M | Sell |
144,917
-12,115
| -8% | -$435K | ﹤0.01% | 2420 |
|
|
2023
Q3 | $6.31M | Buy |
157,032
+96,147
| +158% | +$4.5M | ﹤0.01% | 2100 |
|
|
2023
Q2 | $3.2M | Sell |
60,885
-2,757
| -4% | -$168K | ﹤0.01% | 2633 |
|
|
2023
Q1 | $4.07M | Sell |
63,642
-543
| -0.8% | -$35.4K | ﹤0.01% | 2456 |
|
|
2022
Q4 | $3.12M | Sell |
64,185
-4,715
| -7% | -$296K | ﹤0.01% | 2586 |
|
|
2022
Q3 | $4.86M | Sell |
68,900
-1,313
| -2% | -$112K | ﹤0.01% | 2247 |
|
|
2022
Q2 | $4.98M | Sell |
70,213
-244
| -0.3% | -$15.7K | ﹤0.01% | 2278 |
|
|
2022
Q1 | $5.63M | Buy |
70,457
+2,617
| +4% | +$195K | ﹤0.01% | 2345 |
|
|
2021
Q4 | $6.2M | Sell |
67,840
-2,398
| -3% | -$257K | ﹤0.01% | 2316 |
|
|
2021
Q3 | $9.03M | Sell |
70,238
-4,188
| -6% | -$586K | ﹤0.01% | 1938 |
|
|
2021
Q2 | $11.3M | Sell |
74,426
-2,024
| -3% | -$267K | ﹤0.01% | 1844 |
|
|
2021
Q1 | $8.06M | Buy |
+76,450
| New | +$7.65M | ﹤0.01% | 2050 |
|
|
2020
Q3 | – | Sell |
-10,109
| Closed | -$622K | – | 3781 |
|
|
2020
Q2 | $622K | Sell |
10,109
-1,169
| -10% | -$47.8K | ﹤0.01% | 3118 |
|
|
2020
Q1 | $365K | Sell |
11,278
-2,026
| -15% | -$68.3K | ﹤0.01% | 3236 |
|
|
2019
Q4 | $468K | Sell |
13,304
-532
| -4% | -$17.6K | ﹤0.01% | 3351 |
|
|
2019
Q3 | $357K | Buy |
+13,836
| New | +$421K | ﹤0.01% | 3408 |
|
|
2019
Q2 | – | Sell |
-43,455
| Closed | -$1.49M | – | 3784 |
|
|
2019
Q1 | $1.49M | Buy |
43,455
+19,113
| +79% | +$676K | ﹤0.01% | 2875 |
|
|
2018
Q4 | $776K | Sell |
24,342
-3,360
| -12% | -$131K | ﹤0.01% | 3036 |
|
|
2018
Q3 | $1.33M | Sell |
27,702
-15,070
| -35% | -$617K | ﹤0.01% | 2966 |
|
|
2018
Q2 | $1.33M | Buy |
+42,772
| New | +$1M | ﹤0.01% | 2908 |
|
|
2016
Q1 | – | Sell |
-1,232,843
| Closed | -$8.8M | – | 3857 |
|
|
2015
Q4 | $8.8M | Sell |
1,232,843
-81,077
| -6% | -$657K | 0.01% | 1540 |
|
|
2015
Q3 | $10.2M | Sell |
1,313,920
-720,338
| -35% | -$5.93M | 0.01% | 1458 |
|
|
2015
Q2 | $19.6M | Sell |
2,034,258
-126,298
| -6% | -$1.17M | 0.01% | 1025 |
|
|
2015
Q1 | $16.1M | Buy |
2,160,556
+14,113
| +0.7% | +$103K | 0.01% | 1157 |
|
|
2014
Q4 | $19.6M | Buy |
2,146,443
+194,071
| +10% | +$1.88M | 0.01% | 982 |
|
|
2014
Q3 | $20.8M | Buy |
1,952,372
+120,681
| +7% | +$1.43M | 0.01% | 944 |
|
|
2014
Q2 | $30.8M | Sell |
1,831,691
-5,434
| -0.3% | -$89.4K | 0.02% | 765 |
|
|
2014
Q1 | $34.5M | Sell |
1,837,125
-325,222
| -15% | -$5.24M | 0.02% | 698 |
|
|
2013
Q4 | $35M | Sell |
2,162,347
-306,044
| -12% | -$4.09M | 0.02% | 686 |
|
|
2013
Q3 | $33.4M | Sell |
2,468,391
-454,977
| -16% | -$5.35M | 0.02% | 723 |
|
|
2013
Q2 | $29.7M | Buy |
+2,923,368
| New | +$23.7M | 0.02% | 760 |
|
Other funds holding STAA
BC
YC
MAP
VPM
VCM
AIM
Ameriprise's STAA Position: Q1 2026 in Review
Ameriprise reduced its STAAR Surgical (STAA) stake by 5.9% in Q1 2026, selling an estimated $98.9K and leaving 82,010 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3088.
Ameriprise first reported a position in STAA in Q2 2013 and has held it in 40 quarters since. The position peaked at $35M in Q4 2013. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.
- Ameriprise held 82,010 shares of STAAR Surgical worth $1.53M as of Q1 2026.
- Ameriprise sold 5,183 STAAR Surgical shares in Q1 2026, an estimated $98.9K.
- STAAR Surgical made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3088 holding.
- Ameriprise first reported a position in STAAR Surgical in Q2 2013 and has held it in 40 quarters since.
- Ameriprise's STAAR Surgical position peaked at $35M in Q4 2013.
- 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.